stata version 9 2 (STATA Corporation)
STATA Corporation is a verified supplier 
99
Structured Review
STATA Corporation
stata version 9 2
Stata Version 9 2, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 12601 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stata+9+2/STATA+9%2E0/pmc13035102-90-8-8
Average 99 stars, based on 12601 article reviews
Stata Version 9 2, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 12601 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stata+9+2/STATA+9%2E0/pmc13035102-90-8-8
Average 99 stars, based on 12601 article reviews
stata version 9 2 - by Bioz Stars,
2026-09
99/100 stars
Images
Related Articles
other:Article Title: Meta-Analysis of Combined Therapy with Angiotensin Receptor Antagonists versus ACE Inhibitors Alone in Patients with Heart Failure Article Snippet: We used Article Title: Predictive value of low serum interleukin-33 levels in acute ischemic stroke outcomes Article Snippet: Analyses were performed using GraphPad Prism (version 5.0), R version 2.8.1 with the ROCR package (version 1.0–2), and Article Title: Development and validation of the Diabetes Numeracy Test (DNT) Article Snippet: Article Title: Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential Article Snippet: Control:Article Title: Effect of Antenatal Monthly Sulfadoxine-Pyrimethamine, Alone or with Azithromycin, on Gestational Weight Gain and Anemia during Pregnancy and One Month Postpartum in Malawi: A Randomized Controlled Trial Secondary Analysis. Article Snippet: Low gestational weight gain (GWG) and prenatal anemia are associated with adverse pregnancy, maternal and infant health outcomes.. In a secondary analysis of a single-center, randomized, partially placebo-controlled, outcome assessor-blinded, controlled trial conducted in Malawi from 2003 to 2006, when antiretroviral treatment (ART) for HIV was not widely available, we studied whether GWG can be increased and the prevalence of maternal anemia decreased during pregnancy and at 1 month postpartum through the intermittent preventive treatment in pregnancy (IPTp) of maternal malaria and reproductive tract infections.. The participants ($15-year-old women with uncomplicated second trimester single pregnancies) received either sulfadoxine (1,500 mg) and pyrimethamine (75 mg; SP) twice (control group, n 5 433), monthly SP (n 5 439), or monthly SP and azithromycin (1,000 mg) twice (AZI-SP, n 5 441) during pregnancy. Sequencing:Article Title: Lutein and zeaxanthin for reducing morbidity and mortality in preterm infants Article Snippet: Background Lutein and zeaxanthin are nutrients with antioxidant properties found in the macula of the eye and brain tissue.. They have been reported to play a role in reducing oxidative damage, especially in the eyes and possibly in other organ systems.. Oxygen free radicals are one of the agents postulated to cause tissue damage in preterm infants, which leads to morbidities such as retinopathy of prematurity (ROP), intraventricular haemorrhage (IVH), and necrotising enterocolitis (NEC). Generated:Article Title: Lutein and zeaxanthin for reducing morbidity and mortality in preterm infants Article Snippet: Background Lutein and zeaxanthin are nutrients with antioxidant properties found in the macula of the eye and brain tissue.. They have been reported to play a role in reducing oxidative damage, especially in the eyes and possibly in other organ systems.. Oxygen free radicals are one of the agents postulated to cause tissue damage in preterm infants, which leads to morbidities such as retinopathy of prematurity (ROP), intraventricular haemorrhage (IVH), and necrotising enterocolitis (NEC). |